Avon Lifesciences informs about conversion of warrants in to equity shares

Avon Lifesciences has informed that as per the terms of 10,500,000 Warrants, issued by the Company on August 12, 2015 on preferential basis, the Allotment Committee of the Board of Directors of the Company at the meeting held on December 8, 2015, has upon receipt of balance of 75% consideration aggregating to Rs 3,900,000 has approved allotment of 100,000 Equity Shares upon conversion of equivalent number of warrants at an issue price of Rs 26 per share to the allottee.

The above information is a part of company’s filings submitted to BSE.